Futura Medical plc (LON:FUM – Get Free Report) rose 10.3% during mid-day trading on Wednesday . The company traded as high as GBX 40.60 ($0.51) and last traded at GBX 40.60 ($0.51). Approximately 784,037 shares traded hands during mid-day trading, a decline of 10% from the average daily volume of 875,064 shares. The stock had previously closed at GBX 36.80 ($0.46).
Futura Medical Stock Down 0.8 %
The company has a market capitalization of £123.56 million, a price-to-earnings ratio of -2,030.00 and a beta of 1.26. The business has a 50-day moving average price of GBX 38.42 and a 200-day moving average price of GBX 34.67.
Futura Medical Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Recommended Stories
- Five stocks we like better than Futura Medical
- How to Start Investing in Real Estate
- Roblox: The Bottom Just Fell Out of the Metaverse
- 3 Monster Growth Stocks to Buy Now
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.